Related Experiment Video
Updated: Oct 1, 2026

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons
Published on: August 23, 2016
Nrf2-dependent induction of innate host defense via heme oxygenase-1 inhibits Zika virus replication
Hanxia Huang1, Barry Falgout1, Kazuyo Takeda1
1Food and Drug Administration, Silver Spring, MD, United States.
Abstract:
We identified primary human monocyte-derived macrophages (MDM) as vulnerable target cells for Zika virus (ZIKV) infection. We demonstrate dramatic effects of hemin, the natural inducer of the heme catabolic enzyme heme oxygenase-1 (HO-1), in the reduction of ZIKV replication in vitro. Both LLC-MK2 monkey kidney cells and primary MDM exhibited hemin-induced HO-1 expression with major reductions of >90% in ZIKV replication, with little toxicity to infected cells. Silencing expression of HO-1 or its upstream regulatory gene, nuclear factor erythroid-related factor 2 (Nrf2), attenuated hemin-induced suppression of ZIKV infection, suggesting an important role for induction of these intracellular mediators in retarding ZIKV replication. The inverse correlation between hemin-induced HO-1 levels and ZIKV replication provides a potentially useful therapeutic modality based on stimulation of an innate cellular response against Zika virus infection.
Insights
Hemin reduces Zika virus (ZIKV) replication in human macrophages by inducing heme oxygenase-1 (HO-1). This innate cellular response offers a potential therapeutic strategy against ZIKV infection with minimal toxicity.
Area of Science:
- Virology
- Cell Biology
- Immunology
Background:
- Zika virus (ZIKV) poses a significant public health threat.
- Monocyte-derived macrophages (MDM) are identified as susceptible cells for ZIKV infection.
- Understanding cellular mechanisms to control ZIKV replication is crucial for therapeutic development.
Purpose of the Study:
- To investigate the potential of hemin and its downstream effects in controlling ZIKV replication.
- To elucidate the role of heme oxygenase-1 (HO-1) and nuclear factor erythroid-related factor 2 (Nrf2) in ZIKV infection.
Main Methods:
- In vitro infection of LLC-MK2 cells and primary human monocyte-derived macrophages (MDM) with ZIKV.
- Treatment with hemin to induce heme oxygenase-1 (HO-1) expression.
- Silencing of HO-1 and Nrf2 genes using RNA interference.
- Quantification of ZIKV replication and assessment of cellular toxicity.
Main Results:
- Hemin treatment significantly reduced ZIKV replication by over 90% in both cell types.
- Hemin induced HO-1 expression, which correlated with decreased ZIKV replication.
- Silencing HO-1 or Nrf2 diminished the hemin-mediated suppression of ZIKV.
- Hemin treatment showed minimal toxicity to the infected cells.
Conclusions:
- Hemin effectively inhibits ZIKV replication in macrophages through the induction of HO-1 and Nrf2.
- Stimulation of this innate cellular pathway presents a promising therapeutic avenue for ZIKV infection.
- The findings suggest a novel host-directed strategy against ZIKV.
Related Concept Videos
Arboviral Encephalitis
Inhibitors Of Virion Release

